Skip to main content
Clinical Trials/ACTRN12622000418774
ACTRN12622000418774Active, not recruiting未知

Discovery of New Biomarkers of Cardiac Susceptibility in Fabry Disease that may be used to Improve the Precision of Targeted Fabry-Specific Therapy Delivery

The University of Sydney0 sites50 target enrollmentStarted: March 11, 2022Last updated:
Conditions

Trial Snapshot

Phase
未知
Status
Active, not recruiting
Enrollment
50

Study Overview

Brief Summary

No summary available.

Study Design

Study Type
Observational

Eligibility Criteria

Ages
18 Years to o limit (—)
Sex
All

Inclusion Criteria

  • a) Age 18 years or older
  • b) Males and females
  • c) Genetically confirmed Fabry disease
  • d) Indication for a CMR, or appropriate historical CMR study within 36-months of enrolment; and
  • e) Willing and able to provide informed consent by self

Exclusion Criteria

  • a) Patients highly dependent on medical care and unable to provide informed consent;
  • b) Unwilling or unable to participate in 1-year follow-up
  • c) People with cognitive impairment, intellectual disability, or mental illness that prevent them from providing informed consent for themselves.

Investigators

Similar Trials